U.S., Feb. 1 -- ClinicalTrials.gov registry received information related to the study (NCT06803771) titled 'Surveillance of Pancreatic Health After Diabetes Diagnosis' on Jan. 27.
Brief Summary: The goal of this interventional study is to evaluate if the novel diagnostic blood test, called Avantect can early detect pancreatic cancer in patients diagnosed with type 2 diabetes within the last 6 months.
Participants will:
* attend 3 study visits over 12 months time
* provide a blood sample at each study visit
* complete an anxiety questionnaire at each visit.
Study Start Date: March 03
Study Type: INTERVENTIONAL
Condition:
Diabetes Mellitus
Pancreatic Cancer, Adult
Intervention:
DEVICE: Avantect Pancreatic Cancer Test
Avantect test...